Catalyst Wire Dossier Catalyst Wire Dossier

Bismuth Subcitrate Potassium, Metronidazole, Tetracycline Hydrochloride

· Ingenus Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bismuth Subcitrate Potassium, Metronidazole, Tetracycline Hydrochloride, covering 2023-07-03 to 2023-07-03. Get the full timeline:

Most recent: FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)

See pricing